CCO Oncology Podcast

Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A

Episode Summary

In this podcast episode, listen to Guy A. Young, MD, as he counsels a teenage patient with severe hemophilia A and the patient’s caregiver on treatment options with factor and nonfactor therapies and how these options can affect strategies for optimizing prophylaxis and improving adherence.

Episode Notes

In this episode, listen to Guy A. Young, MD, as he counsels a teenage patient with severe hemophilia A and the patient’s mother on various available treatment options and strategies for optimizing hemophilia A prophylaxis and adherence. Topics include:

• Overcoming challenges to adherence
• Choice of standard vs extended half-life factor VIII vs emicizumab
• Safety and efficacy data with emicizumab

Presenter:

Guy A. Young, MD
Professor of Pediatrics
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

Link to full program:
https://bit.ly/3FxrVk2